Catalent To Purchase Bristol-Myers Squibb’s Biologics And Oral Dose Site In Anagni, Italy
On June 19, Catalent announced it had agreed to purchase Bristol-Myers Squibb’s premier biologics and oral dose form manufacturing facility in Anagni, Italy.
Showing Results 11-20 Of 87 For Italy
Anagni, Italy
Catalent’s Anagni facility is a world-class, late-stage and commercial product launch site offering sterile and biologics manufacturing and secondary packaging with extensive expertise i…
Drug Product CDMO Services
Catalent Biologics’ drug product development and manufacturing services leverage proven expertise from pre-clinical to commercial launch and supply of small molecules, biologics, vaccines, and biosimi…
Anagni, Italy
Catalent’s Anagni facility is a world-class, late-stage and commercial product launch site offering sterile and biologics manufacturing and secondary packaging with extensive expertise in vial filling for aseptic liquid and powder products.
Catalent To Purchase Bristol-Myers Squibb Manufacturing Facility In Anagni, Italy
Bristol-Myers Squibb Company and Catalent, Inc. today announced that Catalent has agreed to purchase Bristol-Myers Squibb’s oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy.